Navigating Surivorship: Lymphedema risk persists long after breast cancer treatment
Chirag Shah, MD, co-director of the breast cancer program, director of strategic growth and director of breast radiation oncology at Cleveland Clinic, speaks to the need for vigilant monitoring for lymphedema for at least three years post breast cancer treatment. Women with breast cancer are at risk for lymphedema long after their treatment concludes, according to study findings.
